Skip to content

Left Bundle Branch Pacing Versus Conventional Pacing in Atrioventricular Block

Left Bundle Branch Pacing Versus Conventional Pacing in Patients With Atrioventricular Node Disorders: a Randomized, Control Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05129098
Enrollment
38
Registered
2021-11-22
Start date
2021-07-13
Completion date
2022-12-20
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Nodal Disease

Brief summary

Recently, the concept of physiological pacing has emerged in the clinical practice, in an attempt to prevent the deteriorating effects of right ventricular pacing in the long-term. Left bundle branch pacing seems to be a safe procedure with promising results that may prevent intraventricular dyssynchony compared with the conventional right ventricular pacing.

Detailed description

In this prospective, randomized study the outcomes regarding echocardiographic indices of dyssynchrony in left bundle branch versus conventional right ventricular pacing in patients with atrioventricular node disease will be compared In recent years, His pacing has demonstrated better results regarding resynchronization compared to conventional biventricular pacing in trials of 3D mapping. However, technical difficulties that relate to unstable lead positioning or inability in succeeding low pacing threshold have led to low success rates. An alternative site of physiological pacing that could possibly overcome these issues, while maintaining ventricular synchrony is left bundle branch pacing. The lead implantation of LBB pacing is performed using the Select Secure (3830) pacing lead. The lead is screwed into the interventricular septum, until left bundle branch pacing is achieved. The randomized patients 24 hours after the procedure are echocardiographically evaluated and indices of mechanical dyssynchrony are recorded. Follow-up is conducted at 3 months, 6 months and one year post-procedure.

Interventions

DEVICELeft bundle branch pacing lead (Select Secure 3830 lead)

Implantation of a left bundle branch pacing lead via sheath

Active fixation lead (standard)

Sponsors

University Hospital of Patras
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age\>18 years old * Patients with atrioventricular block and EF\>50% with a predicted ventricular pacing rate\>20% * Patients with intraventricular septal diameter\>8mm * Written informed consent

Exclusion criteria

* Indication for CRT or ICD device * Patients with no subclavian approach, who are candidates for leadless devices * Presence of severe tricuspid regurgitation * Patients who are candidates for implantation from the right side, as currently the provided tools for left bundle branch pacing fascilitate only left sided pacemaker implantations

Design outcomes

Primary

MeasureTime frameDescription
Echocardiographic dyssynchrony index, as expressed with Global Left Ventricular Myocardial Work Efficiency (GWE) (%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the global left ventricular work efficiency- as a measure of dyssynchrony- will be recorded.

Secondary

MeasureTime frameDescription
Procedure Time (min)1 Day of procedureThe total time required for the completion of the procedure
Fluoroscopy Time (min)1 Day of procedureThe total time of fluoroscopy
Dose Area Product (DAP) (cGy/cm2)1 Day of procedureTotal Radiation Dose as expressed with DAP
Implant success1 Day of procedureSuccessful implantation with pacing threshold\<2 V
Complications associated with pacemaker implantationthrough study completion at 1 year post randomisationGeneral device related complications: pneumothorax, hemothorax, infection, tamponade, hematoma, lead reoperation Specific complications associated with the left bundle branch pacing procedure: intraventricular septum rupture, septal perforator branch injury with subsequent myocardial infarction or lead displacement
B natriuretic peptide measurement (pg/ml)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureBlood samples are extracted in all patients at baseline, 3 months, 6 months and one year after the procedure
Stroke volume index (SVi) (ml/m2)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the SVi will be recorded
Ejection Fraction (EF) (%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the EF will be recorded
Global Longitudinal Strain (GLS) (%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the GLS will be recorded
Left Atrium Strain (%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the Left Atrium Strain will be recorded
Aortic Time- Velocity Integral (TVI) (cm)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the aortic TVI will be recorded
Global Work Index (GWI) (mmHg%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and GWI will be recorded
Global Constructive Work (GCW) (mmHg%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and GCW will be recorded
Global Wasted Work (GWW) (mmHg%)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and GWW will be recorded
Segmental CW, WW at the mid septal wall24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and segmental WI, CW, WW at the mid septal wall will be recorded
Segmental CW, WW at the basal lateral wall24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and segmental WI, CW, WW at the basal lateral wall will be recorded
Peak Strain Dispersion (PSD) (msec)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and PSD will be recorded
Changes in capture threshold (V) in the ventricular lead24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureThe device will be interrogated at baseline, 3 months, 6 months and one year after the procedure and the potential changes in capture threshold in the ventricular lead will be recorded
Changes in sense (mV) in the ventricular lead24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureThe device will be interrogated at baseline, 3 months, 6 months and one year after the procedure and potential changes in sense in the ventricular lead will be recorded
Left Atrium Strain Rate (1/s)24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedureFollow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the Left Atrium Strain Rate will be recorded

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026